Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Clinical implications of prostaglandin inhibition in the small bowel
Autore:
Houchen, CW;
Indirizzi:
Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA Washington Univ St Louis MO USA 63110 stroenterol, St Louis, MO 63110 USA
Titolo Testata:
GASTROENTEROLOGY CLINICS OF NORTH AMERICA
fascicolo: 4, volume: 30, anno: 2001,
pagine: 953 -
SICI:
0889-8553(200112)30:4<953:CIOPII>2.0.ZU;2-3
Fonte:
ISI
Lingua:
ENG
Soggetto:
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ANTI-INFLAMMATORY DRUGS; SMALL-INTESTINAL INFLAMMATION; RANDOMIZED CONTROLLED TRIAL; PLACEBO-CONTROLLED TRIAL; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; GASTROINTESTINAL TOXICITY; PHOSPHOLIPASE A(2); DIAPHRAGM DISEASE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
75
Recensione:
Indirizzi per estratti:
Indirizzo: Houchen, CW Washington Univ, Sch Med, Dept Internal Med, Div Gastroenterol, 660 S Euclid,Box 8124, St Louis, MO 63110 USA Washington Univ 660 S Euclid,Box 8124 St Louis MO USA 63110 SA
Citazione:
C.W. Houchen, "Clinical implications of prostaglandin inhibition in the small bowel", GASTRO CLIN, 30(4), 2001, pp. 953

Abstract

NSAIDs are among the most widely used class of drugs for the treatment of arthritides and other painful conditions. The newer selective cyclooxygenase 2 inhibitors have emerged as an important option in the treatment of these conditions. The widespread acceptance of these agents has brought renewedattention to the role of prostaglandin inhibition in gastroduodenal injury. These newer agents appear to cause less gastroduodenal ulceration and result in fewer significant gastrointestinal complications than traditional NSAIDs. In this article, the author reviews the less recognized complicationsof prostaglandin inhibition in the small intestine.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/03/20 alle ore 15:02:01